Montelukast Prescribing at THE MILLWOOD PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,327
Total Quantity
95.7K
NHS Cost
£4.6K
vs National Avg
+239.8%
THE MILLWOOD PARTNERSHIP prescribed 2,327 items of Montelukast over the last 12 months at a cost of £4,617 to the NHS. This is 239.8% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
189
Jul 2026
177
Jul 2026
209
Jul 2026
201
Jul 2026
205
Jul 2026
186
Jul 2026
186
Jul 2026
208
Jul 2026
191
Jul 2026
180
Jul 2026
200
Jul 2026
195
Prescribing Details
| Total Items | 2,327 |
|---|---|
| Total Quantity | 95,655 |
| Total NHS Cost | £4,617 |
| Presentations | 4 different forms |
| vs National Average | +239.8% |
Montelukast Prescribing Comparison
| This practice | 2,327 items |
|---|---|
| National average per practice | 685 items |
| Difference | +239.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.